Andere talen Green Cross Medical Science Corporation

Aandelen

A142280

KR7142280007

slotkoers Korea S.E. Andere beurzen 00:00:00 03-05-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
4.100 ^KRW	+0,86%		+1,11%	-14,05%

2023

Green Cross Medical Science Corporation rapporteert resultaten voor het eerste kwartaal eindigend op 31 maart 2023

Andere talen

Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!

Gratis inschrijven

Green Cross Medical Science Corporation Reports Earnings Results for the First Quarter Ended March 31, 2023	15-05-23
Green Cross Medical Science Corporation announced that it has received KRW 30 billion in funding from Daishin Securities Co. Ltd., Investment Arm and other investors	04-02-22
Green Cross Medical Science Corporation announced that it expects to receive KRW 30 billion in funding from Daishin Securities Co. Ltd., Investment Arm and other investors	27-01-22
Oxford Immunotec Global PLC Enters into A Memorandum of Understanding Green Cross Medical Science Corp. to Market the T-SPOT Discovery SARS-CoV-2 Kit, for the Measurement of the T Cell Immune Response to SARS-CoV-2 Infection, in South Korea	08-02-21
Hemotune AG announced that it has received CHF 5.1 million in funding from Green Cross Medical Science Corporation, ZKB Start-up Finance, Occident Group AG	23-07-20
Green Cross Medical Science Enters into Co-Development Agreement with GeneCast to Develop A New COVID-19 Detection Kit	24-03-20
GreenCross Medical Science Corp. cancelled the acquisition of additional 29.54% stake in CERAGEM Medisys, Inc.	17-04-19
GreenCross Medical Science Corp. agreed to acquire additional 29.54% stake in CERAGEM Medisys, Inc for KRW 4.6 billion.	17-04-18
GreenCross Medical Science Corp. announced that it has received KRW 10 billion in funding from KB Securities Co., Ltd., Investment Arm and other investors	05-01-18
GreenCross Medical Science Corp. announced that it has received KRW 10 billion in funding from Kiwoom Securities Co., Ltd., Investment Arm, Korea Investment & Securities Co., Ltd., Investment Arm, Industrial Bank of Korea, Investment Arm, and other investors	05-01-18
GreenCross Medical Science Corp. announced that it expects to receive KRW 10 billion in funding from Kiwoom Securities Co., Ltd., Investment Arm, Korea Investment & Securities Co., Ltd., Investment Arm, Industrial Bank of Korea, Investment Arm, and other investors	03-01-18
GreenCross Medical Science Corp. announced that it expects to receive funding from KB Securities Co., Ltd., Investment Arm and other investors	03-01-18
Tranche Update on GreenCross Medical Science Corp.'s Equity Buyback Plan announced on March 2, 2017.	15-05-17
GreenCross Medical Science Corp.'s Equity Buyback announced on March 2, 2017 has closed with 50,000 shares, representing 0.52% for KRW 536.95 million.	10-05-17
GreenCross Medical Science Corp. announces an Equity Buyback for 50,000 shares.	02-03-17
GreenCross Medical Science Corp. authorizes a Buyback Plan.	02-03-17
GreenCross Medical Science Corp. completed the acquisition of 21.06% stake in CERAGEM Medisys, Inc.	31-01-15
GreenCross Medical Science Corp. agreed to acquire a 21.06% stake in CERAGEM Medisys, Inc. for KRW 5 billion.	20-01-15
GreenCross Medical Science Corp. has completed an IPO in the amount of KRW 12.00 billion.	15-12-14
GreenCross Medical Science Corp. has filed an IPO in the amount of KRW 11.20 billion.	17-09-14

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen Green Cross Medical Science Corporation

Aandelen

A142280

KR7142280007

Andere talen

Filters